Amitiza Package Insert

HIGHLIGHTS OF PRESCRIBING INFORMATION Thereafter Or As ...
1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OFEV safely and effectively. See full prescribing information for OFEV. ... View This Document

Amitiza (Lubiprostone) - HID
Texas Prior Authorization Program Clinical Edits Amitiza (Lubiprostone) April 29, 2015 Copyright © 2012-2015 Health Information Designs, LLC 6 ... Fetch Here

HIGHLIGHTS OF PRESCRIBING INFORMATION In Patients With Severe ...
3 Use in Patients with Severe Renal Impairment In patients with severe renal impairment (creatinine clearance less than 30 mL/min), dose reduction of RELISTOR by one-half is recommended [see Use in Specific Populations (8.6)]. ... Access This Document

Adlyxin Prescribing Information - Home - Sanofi
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ADLYXIN safely and effectively. See full prescribing information for ADLYXIN. ... Document Viewer

Therapeutic Class Overview Opioid-Induced Constipation Agents
Therapeutic Class Overview: opioid-induced constipation agents Page 2 of 3 reported only in the FDA-approved package insert. The primary endpoint was the proportion of Amitiza® [package insert]. Deerfield (IL): Takeda Pharmaceuticals America, Inc.; 2013 Apr. ... Visit Document

Amitiza (lubiprostone) Or LinzessTM (linaclotide)
Amitiza ® (lubiprostone) or Linzess. TM (linaclotide) FDA INDICATIONS and USAGE AMITIZA: 1. Amitiza® is indicated for the treatment of chronic idiopathic constipation in adults. 2. Amitiza is indicated for the treatment of opioid -induced constipation (OIC) in adults with chronic non-cancer pain. Limitations of Use: ... Retrieve Doc

HIGHLIGHTS OF PRESCRIBING INFORMATION These Highlights Do Not ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AMITIZA safely and effectively. See full prescribing information ... Access Content

HIGHLIGHTS OF PRESCRIBING INFORMATION ...
FULL PRESCRIBING INFORMATION WARNING: QT PROLONGATION AND SUDDEN DEATHS Tasigna prolongs the QT interval. Prior to Tasigna administration and periodically, monitor for hypokalemia or hypomagnesemia and correct deficiencies (5.2). ... Access Doc

PA Notification Amitiza Linzess Movantik Symproic Trulance ...
Amitiza (lubiprostone) is indicated for the treatment of chronic idiopathic constipation, foropioid induced constipation in chronic non-cancer pain in adults including patients with chronic pain related to prior cancer or its treatment who do not require frequent ... Get Doc

HIGHLIGHTS OF PRESCRIBING INFORMATION These Highlights Do Not ...
CIMZIA is provided in a package that contains everything required to reconstitute and inject the drug [see How Supplied/Storage and Handling (16) ... Document Viewer

AMITIZA (lubiprostone) RATIONALE FOR INCLUSION IN PA PROGRAM
AMITIZA (lubiprostone) Amitiza FEP Clinical Rationale RATIONALE FOR INCLUSION IN PA PROGRAM Background Amitiza is a chloride channel activator. Amitiza is a specific activator of CIC-2 chloride channels in the intestinal epithelium and bypasses the antisecretory action of opiates by activation of apical CIC-2 channels. ... Doc Retrieval

PowerPoint Presentation
11/3/2017 4 Lubiprostone (AMITIZA) Lubiprostone (AMITIZA) • Mechanism: Chloride channel activator Amitiza® [package insert]. Sucampo Pharmaceuticals, Inc., Bethesda, MD; 2006. ... View Doc

PACKAGE LEAFLET - Medicines
PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES Lubiprostone . If you do get nausea, taking AMITIZA with food may reduce the symptoms. If you get severe diarrhoea during treatment or your diarrhoea worsens, tell your doctor immediately. ... View This Document

Takeda Pharmaceutical Company: A Global Leader In ...
A Global Leader in Gastroenterology Takeda Pharmaceutical Company: Investor and Analyst Event March 9th, 2015 W Hotel, New York City 1 Today's Presenters & Panel AMITIZA[package insert]. Bethesda, MD: Sucampo Pharma Americas, LLC; 2013. ... Get Document

WARNINGS AND PRECAUTIONS AMPYRA Can Cause Seizures; The Risk ...
FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE AMPYRA is indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). ... Access Doc

Reference ID: 3220194 - Food And Drug Administration
Amitiza ® is indicated for the treatment of chronic idiopathic constipation in adults. 1.2 Irritable Bowel Syndrome with Constipation . Amitiza is indicated for the treatment of irritable bowel syndrome with constipation (IBS-C) in . women ≥ 18 years old. 2 DOSAGE AND ADMINISTRATION . Amitiza should be taken orally with food and water. ... Get Content Here

HIGHLIGHTS OF PRESCRIBING INFORMATION Take On Empty Stomach ...
1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LINZESS safely and effectively. See full prescribing information ... Access This Document

Therapeutic Class Overview Irritable Bowel Syndrome Agents
Therapeutic Class Overview Irritable Bowel Syndrome Agents Therapeutic Class Overview/Summary: This review will focus on agents used for the treatment of Irritable Bowel Syndrome (IBS).1-5 IBS is a Amitiza® [package insert]. Deerfield (IL): Takeda Pharmaceuticals America, Inc.; 2013 Apr. ... Access Doc

HIGHLIGHTS OF PRESCRIBING INFORMATION Macrovascular Outcomes ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use STARLIX safely and effectively. See full prescribing information for ... Get Doc

HIGHLIGHTS OF PRESCRIBING INFORMATION These Highlights Do Not ...
FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE . 1.1 Chronic Idiopathic Constipation . Amitiza ® is indicated for the treatment of chronic idiopathic constipation in adults. ... Fetch Doc